Stocks · Health care · Pharmaceutical Preparations

Faeth Therapeutics, Inc.

FTH Clue Score45
United States Fiscal year ends December CIK 0001829802 Results filed 3 Nov 2026

What the insiders did Net buying

By person

8 insiders · 96 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Brian C Stephenson
Chief Financial Officer
$1.13M (22)
—
+$1.13M
46,688
$1.13M
—
Cambrian BioPharma Inc entity
10% owner
—
$787.81K (10)
−$787.81K
130,142
$3.15M
−28.7%
James Peyer
10% owner
—
$787.81K (10)
−$787.81K
285,284
$6.91M
−15.5%
Millennium Management LLC entity
10% owner
$1.34M (26)
$704.45K (25)
+$637.27K
133,986
$3.25M
+21.7%
Anand Kiran Parikh
President and CEO
$55.45K (1)
—
+$55.45K
817,699
$19.80M
—
John Celebi
President and CEO
—
—
—
105,862
$2.56M
−5.0%
der Horst Edward van
Chief Scientific Officer
—
—
—
59,794
$1.45M
−3.7%
Stephen M. Hahn
Director
—
—
—
44,763
$1.08M
—

No percentages here. This company's share count has moved by a factor of 20.5 over the window, from 1,261,290 to 25,840,425 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.